NEUROPROTECTIVE EFFECT OF PLANT DERIVED NANOVESICLES IN ISCHEMIA MODEL

Viktorija Kurmytė1, Rokas Nekrošius2, Zbigniev Balion1

1 Preclinical Research Laboratory for Medicinal Products, Institute of Cardiology, Lithuanian University of Health Sciences, Kaunas, Lithuania

2 Clinic of Cardiac, Thoracic and Vascular Surgery, Hospital of Lithuanian University of Health Sciences Kaunas Clinics, Kaunas, Lithuania

Neurological complications are one of the main causes of morbidity and mortality during cardiac surgery characterized by acute ischemic brain lesions, ischemic stroke and inflammation [1]. Existing prevention of ischemic damage (artificial oxygenation and cooling) are insufficient to prevent the damage. Extracellular vesicles (EVs) are nanosized double membraned particles containing cell metabolites, microRNAs, proteins and other substances found in the cells. They are involved in intracellular communication and can pass through blood-brain barrier. Although there is plenty of research done on mammalian EVs, plant derived extracellular vesicles (PDVs) are more scalable and sustainable in comparison [2]. PDVs also exert anti-inflammatory, anti-oxidant, anti-fungal and antimicrobial activity. They contain bioactive metabolites and microRNAs capable of cross-kingdom regulation of gene expression [3]. Unique biological cargo and permeability makes PDVs a good tool for medical applications and might be used during and after cardiac surgery to reduce cerebral damage caused by ischemia.
The aim of this research was to test the neuroprotective effects of PDVs in an ischemic model on mixed neuron-glial cell cultures. For this study, nanovesicles from Rosa Damascena rose buds, cranberries, blueberries, guelder rose, and nettle were isolated using the Exoplant-Lo kit (Exolitus). The Nanosight 300 was used to determine the size and concentration of nanovesicles (nanotracking analysis NTA). RNA concentration was determined using Trizol reagent. Protein concentration was determined using the Bradford method. Primary mixed neuron-glial cell culture was obtained from 5-7 days old Wistar rats. Cells were pretreated with PDVs for 24 hours and then transferred into hypoxic conditions (\(CO_2\) 5%, \(O_2\) 2%, \(N_2\) 95%) for 48h. The percentage of live cells was evaluated with fluorescence microscopy using live/dead fluorescent dyes.

Results indicated that size of obtained nanovesicles was in a range of 50 - 250 nm depending on source plant. PDVs contained significant concentrations of RNA and proteins complying with data found in literature. A range of nanovesicles derived from Rosa Damascena rose buds (1*10\(^{10}\) – 1*10\(^{7}\) particles/ml) had neuroprotective effects on mixed neuronal-glial cell cultures in an ischemic model, while other PDVs had no or toxic effects at higher doses.
In summary, PDVs from Rosa Damascena rose buds prevented cell death in neuronal-glial cells during hypoxia, showing a potential use during cardiac surgeries in order to prevent neurological damage. Also the differences between plant source can highly impact effects of PDVs, as some plant PDVs can have adverse effects depending on concentration.


[1] Lata AL, Hammon JW. Neurologic Complications of Cardiac Surgery [Internet]. In: Baumgartner WA, Jacobs JP, Darling GE, editors. Adult and Pediatric Cardiac Surgery. STS Cardiothoracic Surgery E-Book. Chicago: Society of Thoracic Surgeons; 2023. [cited 2024 January 10]. Available from: ebook.sts.org.

[2] Lian MQ, Chng WH, Liang J, Yeo HQ, Lee CK, Belaid M, et al. Plant‐derived extracellular vesicles: Recent advancements and current challenges on their use for biomedical applications. J Extracell Vesicles. 2022 Dec;11(12):12283.

[3] Alfieri M, Leone A, Ambrosone A. Plant-Derived Nano and Microvesicles for Human Health and Therapeutic Potential in Nanomedicine. Pharmaceutics. 2021 Apr 6;13(4):498.